Connable Office Inc Merck & Co., Inc. Transaction History

Connable Office Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$71.68 - $78.83 $2.64 Million - $2.91 Million	-36,858 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$70.31 - $77.77 $7,031 - $7,777	100 Added 0.27%	36,858 $2.87 Million
Q1 2021 May 07, 2021	BUY	$68.86 - $81.11 $354,215 - $417,229	5,144 Added 16.27%	36,758 $2.83 Million
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $119,868 - $135,872	1,638 Added 5.46%	31,614 $2.62 Million
Q2 2020 Aug 10, 2020	SELL	$70.42 - $80.13 $213,724 - $243,194	-3,035 Reduced 9.19%	29,976 $2.32 Million
Q1 2020 May 08, 2020	BUY	$63.36 - $87.82 $2.09 Million - $2.9 Million	33,011 New	33,011 $2.54 Million

3,831

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $284B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Connable Office Inc, based on Form 13F filings with the SEC.

Stay updated on Connable Office Inc with notifications on news.